Skip to main content
Molecure S.A. logo

Molecure S.A. — Investor Relations & Filings

Ticker · MOC ISIN · PLONCTH00011 LEI · 2594003L11V38ZCVKZ09 WAR Professional, scientific and technical activities
Open in API
Filings indexed 197 across all filing types
Latest filing 2026-03-26 Director's Dealing
Country PL Poland
Listing WAR MOC

About Molecure S.A.

https://molecure.com/

Molecure S.A. is a clinical-stage biotechnology company focused on discovering and developing first-in-class small molecule drugs for diseases with high unmet medical needs. The company utilizes its expertise in medicinal chemistry and biology to identify, validate, and modulate novel protein and mRNA targets. Its therapeutic pipeline is concentrated on oncological, inflammatory, and fibrotic diseases. Molecure operates a proprietary discovery platform for targeting mRNA with small molecules, enabling the development of innovative therapies for previously untreatable conditions.

Recent filings

Filing Released Lang Actions
Informacje o transakcjach na akcjach Spółki otrzymane na podstawie art. 19 MAR - Content (PL)
Director's Dealing Classification · 90% confidence The document is a short current report notifying a MAR Article 19 insider notification from a person discharging managerial responsibilities. This corresponds to a Director’s Dealing report under insider trading regulations. Therefore, it is classified as DIRS.
2026-03-26 Polish
Ustalenie liczby akcji serii K nowej emisji oraz liczby akcji istniejących, które będą przedmiotem ofert ich objęcia lub sprzedaży, a także ustalenie ceny emisyjnej oraz ceny sprzedaży akcji oferow...
Share Issue/Capital Change Classification · 90% confidence The document is a Polish ‘Raport bieżący’ reporting the details of a capital increase: issuance of new Series K shares, sale of existing shares, exclusion of pre-emptive rights, price setting, and related board and shareholder resolutions. This clearly corresponds to a share issue/capital change announcement rather than an annual or interim report or simply a publication notice. Therefore, it falls under Share Issue/Capital Change (SHA).
2026-03-25 Polish
Rozpoczęcie procesu budowania księgi popytu w ramach łącznej oferty publicznej istniejących akcji Molecure S.A. oraz akcji nowej emisji serii K - Content (PL)
Share Issue/Capital Change Classification · 91% confidence The document is a detailed regulatory “raport bieżący” announcing the terms of a new share issuance and capital increase (book-building process for new and existing shares, pre-emptive rights, pricing, timings, legal basis, etc.). It is clearly an announcement of a share issue and capital change, matching the “Share Issue/Capital Change” category.
2026-03-24 Polish
Załącznik 2
Major Shareholding Notification Classification · 87% confidence The document is a notification filed under Articles 69 and 87 of the Polish Public Offering Act detailing direct and indirect shareholdings of parties to a shareholder agreement (porozumienie akcjonariuszy). It discloses percentage holdings before and after the event and is aimed at informing the market of significant share ownership levels. This matches the definition of a Major Shareholding Notification.
2026-03-24 Polish
Załącznik 1
Major Shareholding Notification Classification · 93% confidence The document is a formal notification under Art.69(1),(2) in conjunction with Art.87(1)(5) of the Polish Offer Act, detailing shareholdings and a shareholders’ agreement (“tag along”/pre-emptive purchase rights). It is not a full financial report, earnings release, management change announcement, or AGM material. It clearly relates to changes and notifications of share ownership levels by major shareholders, fitting the Major Shareholding Notification category.
2026-03-24 Polish
Otrzymanie zawiadomień, na podstawie art. 69 ust. 1 lub 2 w zw. z art. 87 ust. 1 pkt 5 ustawy o ofercie, o zawarciu porozumień akcjonariuszy - Content (PL)
Major Shareholding Notification Classification · 75% confidence The document is a brief market disclosure by a Polish issuer informing about receiving notifications under Article 69(1) or (2) in conjunction with Article 87(1)(5) of the Public Offering Act concerning shareholder agreements. In our taxonomy, notifications regarding shareholding levels or shareholder agreements fall under “Major Shareholding Notification” (MRQ). The text is a direct notification rather than the full agreement or an investor presentation, so MRQ is the appropriate category.
2026-03-24 Polish

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.